A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL

NCT05365100 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Due to company decision

Conditions

CLL/SLL
NHL

Interventions

DRUG: BN102

Sponsor

BioNova Pharmaceuticals (Shanghai) LTD.